Faeth Therapeutics (FTH) Earnings Date & Reports

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

FTH is expected to report earnings to fall 72.41% to -78 cents per share on November 10

Faeth Therapeutics FTH Stock Earnings Reports

Q3'26

Est.

$-0.78

Q2'26

Beat

by $1.32

The last earnings report on August 04 showed earnings per share of -283 cents, beating the estimate of -415 cents. With 177.36K shares outstanding, the current market capitalization sits at 717.59M.

View a ticker or compare two or three

FTH

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for FTH